MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 2.790
+0.010 (0.36%)
Aug 3, 2026, 11:44 AM CET
MaaT Pharma Revenue
In the year 2025, MaaT Pharma had annual revenue of 4.52M EUR with 40.67% growth. MaaT Pharma had revenue of 2.10M in the half year ending December 31, 2025, with 146.63% growth.
Revenue
4.52M
Revenue Growth
+40.67%
P/S Ratio
11.58
Revenue / Employee
80.79K
Employees
59
Market Cap
52.39M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.52M | 1.31M | 40.67% |
| Dec 31, 2024 | 3.22M | 987.74K | 44.33% |
| Dec 31, 2023 | 2.23M | 798.26K | 55.82% |
| Dec 31, 2022 | 1.43M | 458.28K | 47.16% |
| Dec 31, 2021 | 971.73K | 309.37K | 46.71% |
| Dec 31, 2020 | 662.36K | -563.64K | -45.97% |
| Dec 31, 2019 | 1.23M | 334.00K | 37.44% |
| Dec 31, 2018 | 892.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| genOway Société anonyme | 28.60M |
| Nicox | 16.77M |
| Fermentalg | 13.38M |
| Innate Pharma | 9.01M |
| Advicenne | 6.40M |
| Sensorion | 5.81M |
| ABIONYX Pharma | 4.06M |
| Adocia | 3.85M |
MaaT Pharma News
- 4 weeks ago - MaaT Pharma Slides: Corporate presentation - Filings
- 6 weeks ago - MaaT Pharma Slides: FY 2026 - Filings
- 2 months ago - MaaT Pharma Earnings release: Q1 2026 - Filings
- 4 months ago - MaaT Pharma Earnings release: H2 2025 - Filings
- 4 months ago - MaaT Pharma Slides: H2 2025 - Filings
- 4 months ago - MaaT Pharma Annual report: H2 2025 - Filings
- 9 months ago - MaaT Pharma Earnings release: Q3 2025 - Filings
- 11 months ago - MaaT Pharma Quarterly report: H1 2025 - Filings